Heritage Family Offices LLP Purchases 197 Shares of Integer Holdings Co. (NYSE:ITGR)

Heritage Family Offices LLP boosted its position in shares of Integer Holdings Co. (NYSE:ITGR) by 6.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,033 shares of the medical equipment provider’s stock after acquiring an additional 197 shares during the period. Heritage Family Offices LLP’s holdings in Integer were worth $402,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of the company. Contravisory Investment Management Inc. lifted its holdings in shares of Integer by 55.9% during the 3rd quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 80 shares during the last quarter. Huntington National Bank increased its position in Integer by 8,933.3% during the 3rd quarter. Huntington National Bank now owns 271 shares of the medical equipment provider’s stock valued at $35,000 after buying an additional 268 shares in the last quarter. Quest Partners LLC raised its stake in Integer by 3,688.9% in the second quarter. Quest Partners LLC now owns 341 shares of the medical equipment provider’s stock valued at $39,000 after buying an additional 332 shares during the last quarter. Versant Capital Management Inc boosted its holdings in Integer by 98.4% in the fourth quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider’s stock worth $49,000 after acquiring an additional 183 shares in the last quarter. Finally, GAMMA Investing LLC grew its stake in shares of Integer by 74.1% during the third quarter. GAMMA Investing LLC now owns 653 shares of the medical equipment provider’s stock worth $85,000 after acquiring an additional 278 shares during the last quarter. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research firms recently commented on ITGR. KeyCorp lifted their target price on shares of Integer from $139.00 to $144.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 15th. Wells Fargo & Company reiterated an “overweight” rating and set a $160.00 price objective on shares of Integer in a research note on Tuesday, December 3rd. Citigroup upped their target price on Integer from $130.00 to $145.00 and gave the company a “neutral” rating in a research report on Wednesday, December 11th. Benchmark lifted their price target on Integer from $130.00 to $140.00 and gave the stock a “buy” rating in a research report on Monday, October 21st. Finally, Truist Financial increased their price objective on Integer from $147.00 to $163.00 and gave the company a “buy” rating in a report on Wednesday, December 11th. One equities research analyst has rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. According to MarketBeat.com, Integer presently has an average rating of “Moderate Buy” and an average target price of $145.44.

Integer Stock Performance

Shares of ITGR stock opened at $139.88 on Thursday. The company has a quick ratio of 2.09, a current ratio of 3.28 and a debt-to-equity ratio of 0.67. Integer Holdings Co. has a 52-week low of $94.56 and a 52-week high of $142.76. The business has a 50-day simple moving average of $136.25 and a 200-day simple moving average of $128.34. The stock has a market cap of $4.69 billion, a PE ratio of 43.17, a price-to-earnings-growth ratio of 1.70 and a beta of 1.12.

Integer (NYSE:ITGR) last issued its quarterly earnings data on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share for the quarter, topping analysts’ consensus estimates of $1.36 by $0.07. The business had revenue of $431.42 million during the quarter, compared to the consensus estimate of $440.59 million. Integer had a net margin of 6.70% and a return on equity of 11.63%. The company’s revenue was up 8.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.27 earnings per share. On average, equities analysts expect that Integer Holdings Co. will post 5.33 EPS for the current year.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.